Comprehensive review of methicillin-resistant Staphylococcus aureus: Screening and preventive recommendations for plastic surgeons and other surgical health care providers

Eamon B. O'Reilly, Mark D. Johnson, Rod J. Rohrich

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Up to 2.3 million people are colonized with methicillin-resistant Staphylococcus aureus in the United States, causing well-documented morbidity and mortality. Although the association of clinical outcomes with community and hospital carriage rates is increasingly defined, less is reported about asymptomatic colonization prevalence among physicians, and specifically plastic surgeons and the subsequent association with the incidence of patient surgical-site infection. Methods: A review of the literature using the PubMed and Cochrane databases analyzing provider screening, transmission, and prevalence was undertaken. In addition, a search was completed for current screening and decontamination guidelines and outcomes. Results: The methicillin-resistant S. aureus carriage prevalence of surgical staff is 4.5 percent. No prospective data exist regarding transmission and interventions for plastic surgeons. No studies were found specifically looking at prevalence or treatment of plastic surgeons. Current recommendations by national organizations focus on patient-oriented point-of-care testing and intervention, largely ignoring the role of the health care provider. Excellent guidelines exist regarding screening, transmission prevention, and treatment both in the workplace and in the community. No current such guidelines exist for plastic surgeons. Conclusions: No Level I or II evidence was found regarding physician screening, treatment, or transmission. Current expert opinion, however, indicates that plastic surgeons and their staff should be vigilant for methicillin-resistant S. aureus transmission, and once a sentinel cluster of skin and soft-tissue infections is identified, systematic screening and decontamination should be considered. If positive, topical decolonization therapy should be offered. In refractory cases, oral antibiotic therapy may be required, but this should not be used as a first-line strategy.

Original languageEnglish (US)
Pages (from-to)1078-1089
Number of pages12
JournalPlastic and Reconstructive Surgery
Volume134
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Health Personnel
Decontamination
Guidelines
Physicians
Therapeutics
Surgical Wound Infection
Soft Tissue Infections
Community Hospital
Expert Testimony
PubMed
Workplace
Surgeons
Organizations
Databases
Anti-Bacterial Agents
Morbidity
Skin
Mortality
Incidence

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Comprehensive review of methicillin-resistant Staphylococcus aureus : Screening and preventive recommendations for plastic surgeons and other surgical health care providers. / O'Reilly, Eamon B.; Johnson, Mark D.; Rohrich, Rod J.

In: Plastic and Reconstructive Surgery, Vol. 134, No. 5, 2014, p. 1078-1089.

Research output: Contribution to journalArticle

@article{f7d2aedd488244c28c0d35b9b8e83d71,
title = "Comprehensive review of methicillin-resistant Staphylococcus aureus: Screening and preventive recommendations for plastic surgeons and other surgical health care providers",
abstract = "Background: Up to 2.3 million people are colonized with methicillin-resistant Staphylococcus aureus in the United States, causing well-documented morbidity and mortality. Although the association of clinical outcomes with community and hospital carriage rates is increasingly defined, less is reported about asymptomatic colonization prevalence among physicians, and specifically plastic surgeons and the subsequent association with the incidence of patient surgical-site infection. Methods: A review of the literature using the PubMed and Cochrane databases analyzing provider screening, transmission, and prevalence was undertaken. In addition, a search was completed for current screening and decontamination guidelines and outcomes. Results: The methicillin-resistant S. aureus carriage prevalence of surgical staff is 4.5 percent. No prospective data exist regarding transmission and interventions for plastic surgeons. No studies were found specifically looking at prevalence or treatment of plastic surgeons. Current recommendations by national organizations focus on patient-oriented point-of-care testing and intervention, largely ignoring the role of the health care provider. Excellent guidelines exist regarding screening, transmission prevention, and treatment both in the workplace and in the community. No current such guidelines exist for plastic surgeons. Conclusions: No Level I or II evidence was found regarding physician screening, treatment, or transmission. Current expert opinion, however, indicates that plastic surgeons and their staff should be vigilant for methicillin-resistant S. aureus transmission, and once a sentinel cluster of skin and soft-tissue infections is identified, systematic screening and decontamination should be considered. If positive, topical decolonization therapy should be offered. In refractory cases, oral antibiotic therapy may be required, but this should not be used as a first-line strategy.",
author = "O'Reilly, {Eamon B.} and Johnson, {Mark D.} and Rohrich, {Rod J.}",
year = "2014",
doi = "10.1097/PRS.0000000000000626",
language = "English (US)",
volume = "134",
pages = "1078--1089",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Comprehensive review of methicillin-resistant Staphylococcus aureus

T2 - Screening and preventive recommendations for plastic surgeons and other surgical health care providers

AU - O'Reilly, Eamon B.

AU - Johnson, Mark D.

AU - Rohrich, Rod J.

PY - 2014

Y1 - 2014

N2 - Background: Up to 2.3 million people are colonized with methicillin-resistant Staphylococcus aureus in the United States, causing well-documented morbidity and mortality. Although the association of clinical outcomes with community and hospital carriage rates is increasingly defined, less is reported about asymptomatic colonization prevalence among physicians, and specifically plastic surgeons and the subsequent association with the incidence of patient surgical-site infection. Methods: A review of the literature using the PubMed and Cochrane databases analyzing provider screening, transmission, and prevalence was undertaken. In addition, a search was completed for current screening and decontamination guidelines and outcomes. Results: The methicillin-resistant S. aureus carriage prevalence of surgical staff is 4.5 percent. No prospective data exist regarding transmission and interventions for plastic surgeons. No studies were found specifically looking at prevalence or treatment of plastic surgeons. Current recommendations by national organizations focus on patient-oriented point-of-care testing and intervention, largely ignoring the role of the health care provider. Excellent guidelines exist regarding screening, transmission prevention, and treatment both in the workplace and in the community. No current such guidelines exist for plastic surgeons. Conclusions: No Level I or II evidence was found regarding physician screening, treatment, or transmission. Current expert opinion, however, indicates that plastic surgeons and their staff should be vigilant for methicillin-resistant S. aureus transmission, and once a sentinel cluster of skin and soft-tissue infections is identified, systematic screening and decontamination should be considered. If positive, topical decolonization therapy should be offered. In refractory cases, oral antibiotic therapy may be required, but this should not be used as a first-line strategy.

AB - Background: Up to 2.3 million people are colonized with methicillin-resistant Staphylococcus aureus in the United States, causing well-documented morbidity and mortality. Although the association of clinical outcomes with community and hospital carriage rates is increasingly defined, less is reported about asymptomatic colonization prevalence among physicians, and specifically plastic surgeons and the subsequent association with the incidence of patient surgical-site infection. Methods: A review of the literature using the PubMed and Cochrane databases analyzing provider screening, transmission, and prevalence was undertaken. In addition, a search was completed for current screening and decontamination guidelines and outcomes. Results: The methicillin-resistant S. aureus carriage prevalence of surgical staff is 4.5 percent. No prospective data exist regarding transmission and interventions for plastic surgeons. No studies were found specifically looking at prevalence or treatment of plastic surgeons. Current recommendations by national organizations focus on patient-oriented point-of-care testing and intervention, largely ignoring the role of the health care provider. Excellent guidelines exist regarding screening, transmission prevention, and treatment both in the workplace and in the community. No current such guidelines exist for plastic surgeons. Conclusions: No Level I or II evidence was found regarding physician screening, treatment, or transmission. Current expert opinion, however, indicates that plastic surgeons and their staff should be vigilant for methicillin-resistant S. aureus transmission, and once a sentinel cluster of skin and soft-tissue infections is identified, systematic screening and decontamination should be considered. If positive, topical decolonization therapy should be offered. In refractory cases, oral antibiotic therapy may be required, but this should not be used as a first-line strategy.

UR - http://www.scopus.com/inward/record.url?scp=84925033498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925033498&partnerID=8YFLogxK

U2 - 10.1097/PRS.0000000000000626

DO - 10.1097/PRS.0000000000000626

M3 - Article

C2 - 25347639

AN - SCOPUS:84925033498

VL - 134

SP - 1078

EP - 1089

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 5

ER -